In a recent blog, CAPS player TheMiracleDJR discussed setting up a "wise and mature" portfolio using "a base of highly recognizable, mostly consumer facing stocks that I understand and can opine on, and might actually invest in as I see values of my favorites drop." Sounds like a good idea.

The Motley Fool's CAPS screener went to work with my take at screen settings for wise and mature stocks.

  • Market capitalization greater than $10 billion.
  • Price-to-earnings ratio positive and less than 18.
  • Long-term debt to equity ratio less than two.
  • Current dividend yield of at least 2.5% -- a bit more than the S&P 500 average.
  • Earnings growth rate for the past three years greater than 2.5%.
  • Finally, a CAPS rating or four or five stars (out of five) to focus on companies our Foolish community believes are the best prospects.

Company

Current Dividend Yield

EPS Growth Rate
(last 3 years)

P/E Ratio (TTM)

CAPS Rating

Payout Ratio

Est. Annual Earnings Growth
(next 5 years)

Colgate-Palmolive (NYSE: CL)

2.7%

10.8%

18.1

****

44%

9.1%

Kimberly-Clark (NYSE: KMB)

4.1%

2.8%

15.5

*****

61%

6.6%

BlackRock (NYSE: BLK)

2.8%

13.4%

17.2

****

39%

12.7%

AstraZeneca (NYSE: AZN)

4.9%

15.2%

9.3

****

43%

1.6%

McDonald's (NYSE: MCD)

3.0%

21.6%

17.1

****

49%

10.3%

Intel (Nasdaq: INTC)

3.1%

21.2%

10.9

****

30%

11.8%

NextEra Energy (NYSE: NEE)

3.8%

6.7%

14.6

*****

51%

5.5%

Sources: Motley Fool screener results and Yahoo! Finance. TTM = trailing 12 months.

The seven stocks cover six sectors. In addition, each of these has at least a bit of the consumer-facing business that TheMiracleDJR is looking for.

  • Colgate-Palmolive and Kimberly-Clark products are in nearly every household.
  • BlackRock's iShares ETFs are in many portfolios and have become increasingly popular.
  • Prescriptions for AstraZeneca medicines get filled every day.
  • McDonald's serves millions daily.
  • Intel chips power our computers.
  • NextEra provides power to millions of homes.

Even though this list looks like a nice, core portfolio, the results are just a starting point for further research, not outright buy recommendations.

What's your opinion? Add your favorite core holding with a comment below.

Related Foolishness: